Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell × avelumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Transitional Cell 13 Urinary Bladder Neoplasms 12 Neoplasms 8 Carcinoma, Renal Cell 8 Carcinoma, Merkel Cell 8 Neoplasm Metastasis 7 Breast Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Triple Negative Breast Neoplasms 4 Stomach Neoplasms 4 Ovarian Neoplasms 4 Melanoma 4 Carcinoma, Non-Small-Cell Lung 4 Uterine Cervical Neoplasms 3 Ureteral Neoplasms 3 Skin Neoplasms 3 Prostatic Neoplasms 3 Colorectal Neoplasms 3 Urethral Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Hepatocellular 2 Urothelial Cancer 1 Turcot syndrome 1 Thymoma 1 Peritoneal Neoplasms 1 Penile Squamous Cell Carcinoma (PSCC) 1 Penile Neoplasms 1

Interventions

Cyclophosphamide 8 Biopsy 8 Specimen Handling 7 pembrolizumab 6 fludarabine 6 Whole-Body Irradiation 6 Magnetic Resonance Spectroscopy 6 Peripheral Blood Stem Cell Transplantation 5 Brentuximab Vedotin 5 fludarabine phosphate 4 duvelisib 4 Melphalan 4 10-propargyl-10-deazaaminopterin 4 ruxolitinib 3 X-Rays 3 Mycophenolic Acid 3 Immunoglobulin G 3 Gemcitabine 3 Disulfides 3 tazemetostat 2 sodium-iodide symporter 2 romidepsin 2 cemiplimab 2 belinostat 2 Sirolimus 2 Rituximab 2 Photons 2 Pharmacogenomic Variants 2 Nivolumab 2 Lenalidomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡